Related Experiment Videos
Cyclic expression of low-dose paralysis
Prior treatment (priming) with a single injection of a subimmunogenic dose of Type III pneumococcal polysaccharide results in an antigen-specific T-cell-dependent form of unresponsiveness (low-dose paralysis) mediated by suppressor T cells. Although such unresponsiveness persists for several months after priming, it is expressed in a cyclic manner with a periodicity of about 3 days. This cyclic pattern is accompanied by concurrent periods of Velban sensitivity that also are cyclic. This suggests that the maintenance of low-dose paralysis in part requires some degree of cell proliferation which proceeds in an ordered manner in response to a "signal" generated after priming with antigen.
Prior treatment (priming) with a single injection of a subimmunogenic dose of Type III pneumococcal polysaccharide results in an antigen-specific T-cell-dependent form of unresponsiveness (low-dose paralysis) mediated by suppressor T cells. Although such unresponsiveness persists for several months after priming, it is expressed in a cyclic manner with a periodicity of about 3 days. This cyclic pattern is accompanied by concurrent periods of Velban sensitivity that also are cyclic. This suggests that the maintenance of low-dose paralysis in part requires some degree of cell proliferation which proceeds in an ordered manner in response to a "signal" generated after priming with antigen.